ESC 365 - The effect of a selective urate reabsorption inhibitor dotinurad on uric acid and renal function in patients with hyperuricemia and hypertension.

ESC2025 Premium Access

The effect of a selective urate reabsorption inhibitor dotinurad on uric acid and renal function in patients with hyperuricemia and hypertension.

Session: Therapeutic approaches to hypertension and its comorbidities

Topic: Pharmacotherapy

Speaker: Doctor T. Mizoguchi (Nagoya, JP)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Tatsuya Mizoguchi

Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan)

0 follower

3 more presentations in this session

Blood pressure lowering treatment for prevention of cardiovascular diseases in people with and without chronic kidney disease: an individual participant-level data meta-analysis

Speaker: Ms G. Zeng (Beijing, CN)

App-based multimodal lifestyle-intervention for essential hypertension: a randomized-controlled, decentralized trial in Germany

Speaker: Professor F. Limbourg (Hannover, DE)

Impact of plateau on antihypertensive efficacy among hypertensive highlanders : a post hoc analysis of the OMAN Trial

Speaker: Doctor X. Zuo (Sichuan, CN)

Access the full session

Therapeutic approaches to hypertension and its comorbidities

Speakers: Doctor T. Mizoguchi, Ms G. Zeng, Professor F. Limbourg, Doctor X. Zuo

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources